Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

NCT05930951 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped toxicity

Conditions

Adenoid Cystic Carcinoma of the Head and Neck

Interventions

DRUG: OBT076
DRUG: Balstilimab

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou